LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Metrics to compare | LNSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLNSRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.0x | −3.4x | −0.4x | |
PEG Ratio | 0.39 | −0.05 | 0.00 | |
Price/Book | −2.6x | 2.3x | 2.6x | |
Price / LTM Sales | 1.2x | 3.5x | 3.2x | |
Upside (Analyst Target) | 49.1% | 52.7% | 51.4% | |
Fair Value Upside | Unlock | 15.6% | 6.7% | Unlock |